Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging

Simone Schuerle1, Maiko Furubayashi2,3, Ava P Soleimany4,5,6

  • 1Institute for Translational Medicine, Department of Health Sciences and Technology , ETH Zurich , CH-8092 Zurich , Switzerland.

ACS Synthetic Biology
|January 11, 2020
PubMed
Summary

Genetically engineered magnetic nanoparticles displaying targeting peptides show promise for cancer imaging. These novel magnetosomes enhance tumor targeting and MRI contrast, aiding in cancer diagnosis and treatment.